Treatment for MCI: is the evidence sufficient?
Aisen
Paul S
PS
D000544:Alzheimer Disease / Q000209:etiology / Q000517:prevention & control / Q000523:psychology; D002986:Clinical Trials as Topic / Q000379:methods; D003072:Cognition Disorders / Q000150:complications / Q000523:psychology / Q000628:therapy*; D005702:Galantamine / Q000627:therapeutic use; D006801:Humans
D005702:Galantamine